1. Aoki N, Saito H, Kamiya T, Koie K, Sakata Y, Kobakura M. Congenital deficiency of α2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest 1979; 63:877-84.
2. Mutch N, Thomas L, Moore N, Lisiak K, Booth N. TAFIa, PAI-1 and a2-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots. Journal of thrombosis and haemostasis: JTH 2007; 5: 812-7.
3. Hirosawa S, Nakamura Y, Miura O, Sumi Y, Aokin N. Organization of the human alpha 1-plasmin inhibitor gene. Proceedings of the National Academy of Sciences of the United States of America 1988;85:6836-40.
4. Abdul S, Leebeek FWG, Rijken DC, Uitte de Willige S. Natural heterogeneity of α2-antiplasmin: functional and clinical consequences. Blood 2016; 127: 538-545.
5. Carpenter S, Mathew P. Alpha 2-antiplasmin and its deficiency: fibrinolysis out of balance. Haemophilia: the official journal of the World Federation of Hemophilia 2008; 14:1250-4.
6. Fraser SR, Booth NA, Mutch NJ. The antifibrinolytic function of factor XIII is exclusively expressed through a2-antiplasmin cross-linking. Blood 2011; 117: 6371-6374.
7. Favier R, Aoki N, de Moerloose P. Congenital α2-plasmin inhibitor deficiencies: a review. Br J Haematol 2001; 114: 4-10.
8. Kozyreva O, Bleibel S. Alpha2-Plasmin Inhibitor Deficiency. Available at http://emedicinemedscapecom/article/198336-overview#showall: WebMD; 2012.
9. Hanss M, Farcis M, French P, de Mazancourt P, Dechavanne M. A splicing donor site point mutation in intron 6 of the plasmin inhibitor (alpha 2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency. Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis 2003; 14:107-11.
10. Maino A, Garagiola I, Artoni A, Al-Humood S, Peyvandi F. A novel mutation of alpha 2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency. Haemophilia 2008; 14:166-9.
11. Ikematsu S, Fukutake K, Aoki N. Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age Thromb Res 1996;82:129-36
12. Dawley B. Alpha II antiplasmin deficiency complicating pregnancy: a case report. Obst Gynecol Int 2011; doi: 10.1155/2011/698648.
13. Juhan-Vague I, Alessi M, Declerck P. Pathophysiology of fibrinolysis. Ballieres Clin Haem 1995; 8:329-43.
14. Miyauchi Y, Mii Y, Aoki M, Tamai S, Takahashi Y, A Y. Operative treatment of intramedullary hematoma associated with congenital deficiency of α2-plasmin inhibitor: a report of three cases. J Bone Joint Surg Am 1996; 78:1409-14.
Rare Coagulation Disorders Resource Room, an extension of the RBDD Registry (eu.rbdd.org), was developed in collaboration with the Indiana Hemophilia & Thrombosis Center (www.innovativehematology.org).
The Resource Room serves as a platform to promote international collaboration to increase knowledge of these very rare disorders and to improve the care of affected individuals. The international RBDD mission, under the leadership of Dr. Peyvandi, will continue to be expanded over time.
The Resource Room thanks all contributing authors of the website articles that have made this valuable information available to the global community of both individuals affected with rare coagulation disorders and their healthcare providers.
